Empire Life Investments’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-106,221
Closed -$13.4M 122
2025
Q4
$13.4M Sell
106,221
-924
-0.9% -$121K 0.75% 48
2025
Q3
$15.7M Buy
107,145
+275
+0.3% +$41.6K 0.92% 41
2025
Q2
$16.7M Sell
106,870
-8,605
-7% -$1.36M 1.06% 36
2025
Q1
$19M Sell
115,475
-5,167
-4% -$859K 1.24% 29
2024
Q4
$19.7M Buy
120,642
+3,790
+3% +$678K 1.23% 29
2024
Q3
$22.8M Sell
116,852
-1,440
-1% -$265K 1.39% 25
2024
Q2
$20.5M Buy
118,292
+36,841
+45% +$6.13M 1.29% 30
2024
Q1
$13.8M Buy
81,451
+55,076
+209% +$10.3M 0.85% 47
2023
Q4
$5.21M Buy
+26,375
New +$4.67M 0.34% 60

Other funds holding ZTS

Empire Life Investments's ZTS Position: Q1 2026 in Review

Empire Life Investments sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 106,221 shares — an estimated $13.4M sold.

Empire Life Investments first reported a position in ZTS in Q4 2023 and held it in 9 quarters. The position peaked at $22.8M in Q3 2024. 1,606 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Empire Life Investments reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • Empire Life Investments sold 106,221 Zoetis shares in Q1 2026, an estimated $13.4M.
  • Empire Life Investments first reported a position in Zoetis in Q4 2023 and held it in 9 quarters.
  • Empire Life Investments's Zoetis position peaked at $22.8M in Q3 2024.
  • 1,606 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Empire Life Investments's 13F filing for Q1 2026, filed 11 May 2026.